Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation

Monday, April 6, 2020 1 min read

Key Takeaway: Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation

Full Press Release Details

Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation.